The aforementioned interaction appears to be modulated by the nuclear receptor known as peroxisome proliferator-activated receptor gamma (PPARγ), which is highly expressed in pancreatic tumors and is associated with unfavorable patient outcomes. The gene discussed is PPARG; the disease is pancreatic neoplasm.